GRIN2D and early-onset autosomal dominant Alzheimer disease: Memantine is an Alzheimer’s disease drug that strongly impacts cognitive function by preferentially inhibiting GluN2C-containing and/or GluN2D-containing NMDARs (Kotermanski and Johnson, 2009; Kotermanski et al., 2009).